HER2 and response to paclitaxel in node-positive breast cancer.
New England Journal of Medicine.
Times cited: 478
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: Results of cancer and leukemia group B trial 159806.
Breast Cancer Research and Treatment.
Times cited: 17